<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Unichem Laboratories Limited — News on 6ix</title>
<link>https://6ix.com/company/unichem-laboratories-limited</link>
<description>Latest news and press releases for Unichem Laboratories Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 11 Jan 2024 16:54:54 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/unichem-laboratories-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683650db78dffbe2df15578b.webp</url>
<title>Unichem Laboratories Limited</title>
<link>https://6ix.com/company/unichem-laboratories-limited</link>
</image>
<item>
<title>Press Release Jan 11 2024</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-jan-11-2024-11</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-jan-11-2024-11</guid>
<pubDate>Thu, 11 Jan 2024 16:54:54 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2024, titled "Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg.".</description>
</item>
<item>
<title>Press Release Aug 29 2023</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-29-2023-17</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-29-2023-17</guid>
<pubDate>Tue, 29 Aug 2023 22:14:45 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated August 29, 2023, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015".</description>
</item>
<item>
<title>Press Release Apr 24 2023</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-apr-24-2023-18</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-apr-24-2023-18</guid>
<pubDate>Mon, 24 Apr 2023 19:49:04 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated April 24, 2023, titled "Press Release".</description>
</item>
<item>
<title>Press Release Mar 17 2023</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-17-2023-8</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-17-2023-8</guid>
<pubDate>Fri, 17 Mar 2023 15:35:41 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2023, titled "Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem s Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg.".</description>
</item>
<item>
<title>Press Release Oct 14 2022</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-oct-14-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-oct-14-2022-13</guid>
<pubDate>Fri, 14 Oct 2022 14:30:46 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange about press release dated 14-Oct-2022 titled Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Extended Phenytoin Sodium Capsules USP, 100 mg.</description>
</item>
<item>
<title>Press Release Aug 23 2022</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-23-2022-7</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-23-2022-7</guid>
<pubDate>Tue, 23 Aug 2022 14:48:17 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange about press release dated 23-Aug-2022 pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Carbamazepine Tablets</description>
</item>
<item>
<title>Press Release Aug 16 2022</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-16-2022-15</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-16-2022-15</guid>
<pubDate>Tue, 16 Aug 2022 14:24:47 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange about press release dated 16-Aug-2022 titled ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Quetiapine Extended-Release Tablets USP.</description>
</item>
<item>
<title>Press Release Mar 16 2022</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-16-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-16-2022-13</guid>
<pubDate>Wed, 16 Mar 2022 13:47:53 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange about press release dated 16-Mar-2022 titled ANDA approval from United States Food and Drug Administration (USFDA) for Unichem���s Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.</description>
</item>
<item>
<title>Press Release Feb 28 2022</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-feb-28-2022-11</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-feb-28-2022-11</guid>
<pubDate>Mon, 28 Feb 2022 16:10:20 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange about press release dated 28-Feb-2022 titled ANDA Approval for Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg</description>
</item>
<item>
<title>Press Release Aug 12 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-12-2021-31</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-aug-12-2021-31</guid>
<pubDate>Thu, 12 Aug 2021 18:10:32 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated August 12, 2021, titled "Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg.".</description>
</item>
<item>
<title>Press Release Jul 10 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-jul-10-2021-3</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-jul-10-2021-3</guid>
<pubDate>Sat, 10 Jul 2021 16:32:31 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated July 10, 2021, titled "Press Release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) ".</description>
</item>
<item>
<title>Press Release Jun 30 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-jun-30-2021-13</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-jun-30-2021-13</guid>
<pubDate>Thu, 01 Jul 2021 02:38:17 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated Jun 30, 2021, titled "Press release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) for Aripiprazole Tablets".</description>
</item>
<item>
<title>Press Release May 20 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-may-20-2021-9</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-may-20-2021-9</guid>
<pubDate>Thu, 20 May 2021 18:14:16 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated May 20, 2021, titled "Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Amitriptyline HCl Tablets USP".</description>
</item>
<item>
<title>Press Release Mar 04 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-04-2021-10</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-mar-04-2021-10</guid>
<pubDate>Thu, 04 Mar 2021 20:58:13 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated March 04, 2021, titled "Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Guanfacine Tablets".</description>
</item>
<item>
<title>Press Release Feb 19 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-feb-19-2021-7</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-feb-19-2021-7</guid>
<pubDate>Fri, 19 Feb 2021 15:35:22 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Apremilast Tablets, 10 mg, 20 mg and 30 mg.".</description>
</item>
<item>
<title>Press Release Jan 27 2021</title>
<link>https://6ix.com/company/unichem-laboratories-limited/news/press-release-jan-27-2021-26</link>
<guid isPermaLink="true">https://6ix.com/company/unichem-laboratories-limited/news/press-release-jan-27-2021-26</guid>
<pubDate>Wed, 27 Jan 2021 18:53:23 GMT</pubDate>
<description>Unichem Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2021, titled "Announcement Under Regulation 30 (LODR) - ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg.".</description>
</item>
</channel>
</rss>